SciEmploy.ca » Montreal

Bristol-Myers Squibb

Jeff — Fri, 05 Feb 2010 22:04:50 +0000

With nearly 80 years in Canada, Bristol-Myers Squibb Canada is positioned to be a leading contributor to Canada’s global reputation in the health and pharmaceutical business.

Canada has been indispensable in helping Bristol-Myers Squibb Canada live up to its pledge of fostering a globally diverse work force. Together our employees represent many cultures and backgrounds, but are bound together by the desire to extend and enhance human life.

Biophage Pharma

Jeff — Wed, 03 Feb 2010 21:55:40 +0000

Biophage Pharma Inc. is a Canadian biopharmaceutical company developing, via its fully own subsidiary Biophage Inc., new products in an integrated approach against bacterial infections: combining therapeutic and diagnostic products based on phage technology.

ArthroLab

Jeff — Sun, 10 Jan 2010 07:28:47 +0000

ArthroLab Inc., headquartered in Montreal, Quebec, Canada, was incorporated in May 1994 by Doctors Jean-Pierre Pelletier and Johanne Martel-Pelletier. The company’s initial objective was to perform preclinical (in vitro and in vivo in animals) and clinical trials on a contractual basis for pharmaceutical companies engaged in the development of new agents for the treatment of osteoarthritis.

AMEC

Jeff — Sun, 10 Jan 2010 04:49:02 +0000

With annual revenues of over £2.6 billion, we have major operations in the UK and Americas and work internationally for customers from the Arctic to Australia, employing almost 22,000 people in around 40 countries worldwide. From scientists and environmental consultants, to engineers and project managers,
it is our people who drive our success.

Algorithme Pharma

Jeff — Sun, 10 Jan 2010 04:24:47 +0000

At Algorithme Pharma we pilot through the ever-changing process of achieving market approval for your products. Our knowledge and our resources allow us to do so effectively and within the appropriate timelines. This way you can have your peace of mind while knowing that we will constantly provide you with results that are worthy of approval.

Aegera Therapeutics

Jeff — Sat, 09 Jan 2010 19:12:04 +0000

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.